Johnson & Johnson JNJ announced entering into an exclusive global licensing agreement with Kaken Pharmaceutical to develop, ...

Rinvoq is an oral medication that falls into the drug classification ... the company notes that Rinvoq relieves symptoms of moderate to severe eczema (atopic dermatitis), rheumatoid arthritis ...